Unibest
← Back to patent-cliff list

CAS 1255908-99-6

3-Nitro-5-[1(S)-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]thieno[3,4-c]pyrrole-4,6-dione

Codes: (VIII)989842-1-a

Application context (from source-drug indications)

Plaque psoriasisMufemilastUlcerative colitisMufemilastBehçet's syndromeMufemilastPsoriasisMufemilastChronic obstructive pulmonary diseaseMufemilastAtopic dermatitisMufemilast

Source drugs (routes using this intermediate)

DrugTierExpiry
MufemilastTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

MufemilastOptimised routesteps: 8total yield: /
3,4-Bis(bromanyl)thiophene→3,4-Dicyanothiophene→Thiophene-3,4-dicarboxylic acid→1H,3H-Thieno[3,4-c]furan-1,3-dione→2-Nitrothiophene-3,4-dicarboxylic acid→4-Nitro-1H,3H-thieno[3,4-c]furan-1,3-dione→(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine→3-Nitro-5-[1(S)-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]thieno[3,4-c]pyrrole-4,6-dione→1-Amino-5-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methanesulfonyl)ethyl]-4H-thieno[3,4-c]pyrrole-4,6(5H)-dione→Acetic acid acetic anhydride→Acetic acid chloride

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.